Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp

<< Previous

Bullboard Posts

Next >>

Post by Iseneschalon May 06, 2021 12:06pm

118 Views

Post# 33141143

Baust 100

And just to keep this "Real"............. LEXX trades on the Nasdaq Capital Market

All I can say is that most of these Companies that are listed on the 3 tier NASDAQ are "sh8t"...
You want me to waste my time talking Fundamental of a Co that can Change it's Hat with a swipe of a pen?
LEXX make money thru Liscencing..... and a paltry $200,000 at best

I would say that the reason for the share price appreciation is so they can raise money.....Let's talk about this later......I'm busy scalping this P.O.S

Cheers !

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Gold Report – Nov. 6, 2024